Table 4.
Not developing TB (N = 22,920) | Developing TB (N = 674) | p value | |
---|---|---|---|
Age (years) |
54.2 ± 23.1 |
65.9 ± 11.4 |
<0.001* |
Follow-up duration (years) |
8.6 ± 2.5 |
4.6 ± 2.6 |
<0.001* |
Male |
14,110 (61.6) |
525 (77.9) |
<0.001# |
Diabetes mellitus |
1,566 (6.8) |
55 (8.2) |
0.179# |
Malignancy |
341 (1.5) |
8 (1.2) |
0.524# |
lung cancer |
36 (0.2) |
1 (0.1) |
>0.999‡ |
other cancer |
305 (1.3) |
7 (1.0) |
0.513# |
Autoimmune disease |
68 (0.3) |
2 (0.5) |
>0.999‡ |
End-stage renal disease |
35 (0.2) |
2 (0.3) |
0.285‡ |
Liver cirrhosis |
8 (0.0) |
0 (0) |
>0.999‡ |
Pneumoconiosis |
2 (0.0) |
0 (0) |
>0.999‡ |
Transplantation |
4 (0.0) |
0 (0) |
>0.999‡ |
HIV/AIDS |
0 (0) |
0 (0) |
|
Low income | 335 (1.5) | 11 (1.6) | 0.717# |
HIV: human immunodeficiency virus, AIDS: acquired immunodeficiency syndrome; TB: tuberculosis;
Data are shown as mean ± SD or No. (%) unless otherwise indicated.
* calculated by the independent-samples t test.
# calculated by the chi-square test.
‡ calculated by Fisher’s exact test.